Investigator site 103 - US0010097 — Philadelphia, Pennsylvania

Investigator site 103 - US0010097 is a clinical research site located in Philadelphia, Pennsylvania, United States 19140.

Crixeo Health Trust Score: 44/100 (POOR). This profile has not yet been claimed by the site owner.

Investigator site 103 - US0010097 has participated in 1 clinical trials.

Therapeutic areas: Pemphigus Vulgaris, Pemphigus Foliaceus.

Sponsors: argenx.

Sponsor Feasibility Report

Trust Score: 44/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigator site 103 - US0010097?

Investigator site 103 - US0010097 has a Crixeo Trust Score of 44/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigator site 103 - US0010097 conducted?

Investigator site 103 - US0010097 has 1 clinical trials on record. Their work covers Pemphigus Vulgaris, Pemphigus Foliaceus.

Is Investigator site 103 - US0010097 accredited by Crixeo Health?

Investigator site 103 - US0010097 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigator site 103 - US0010097?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.